Summit Therapeutics
SMMT
#778
Rank
NZ$42.64 B
Marketcap
$57.80
Share price
4.10%
Change (1 day)
820.03%
Change (1 year)

EPS for Summit Therapeutics (SMMT)

EPS in 2023 (TTM): -$2.70

According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.81. In 2022 the company made an earnings per share (EPS) of -$0.84 an increase over its 2021 EPS that were of -$1.60.

EPS history for Summit Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.70222.56%
2022-$0.84-47.8%
2021-$1.60
2019-$0.35159.55%
2018-$0.14
2015-$1.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$13.08 365.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.18-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.55 97.49%๐Ÿ‡บ๐Ÿ‡ธ USA